Edward Nieuwenhuis new Chief Medical Officer at Princess Máxima Center
Prof. Dr. Edward Nieuwenhuis has been appointed the new Chief Medical Officer (CMO) of the Princess Máxima Center. Nieuwenhuis succeeds Prof. Dr. Rob Pieters, whose term expires on 1 January 2025. Nieuwenhuis was head of pediatrics at UMC Utrecht’s Wilhelmina Children’s Hospital for 11 years. Nieuwenhuis will start as CMO on 1 February 2025.
Prof. Dr. Nieuwenhuis has extensive experience in healthcare and science, combined with a wide (inter)national network. He also has comprehensive managerial experience. From 2009-2020, Nieuwenhuis was head of pediatrics at the Wilhelmina Children’s Hospital, the children’s hospital of UMC Utrecht. From that role, he is very familiar with the Princess Máxima Center and the creation of the research hospital. From 2020-2024, he was director of research and professor of biomedical and life sciences at University College Roosevelt in Middelburg. Since 2024, Nieuwenhuis has served as chairman of the Rare Disease Center at Erasmus MC in Rotterdam.
Ir. Rokus van Iperen, chairman of the Supervisory Board of the Princess Máxima Center, says: ‘We are very pleased to have Edward Nieuwenhuis as our new Chief Medical Officer. We are confident that with his vision, managerial experience and connecting qualities, he will make a valuable contribution to realizing the strategic goals of the Princess Máxima Center.’
Prof. Edward Nieuwenhuis, future Chief Medical Officer of the Princess Máxima Center, says: ‘The Princess Máxima Center has a special mission. With the board of directors, clinical directors and all staff at this unique center, I hope to strengthen the connections between children, parents, healthcare professionals, departments, nurses and researchers. No one can accomplish such a wonderful mission better than all of us together!’
Internationalization
Nieuwenhuis succeeds Prof. Dr. Rob Pieters, whose term as CMO of the Princess Máxima Center will end on 1 January 2025. With Pieters’ new role as Chief Máxima International, the Princess Máxima Center aims to accelerate internationalization, an important part of its multi-year strategy. Every form of pediatric cancer is rare. Therefore, international collaboration is essential in the care of children with cancer and pediatric cancer research. Rob Pieters will combine the role of CMI with his position as president of SIOP, the International Society of Paediatric Oncology.
Supervisory Board Chairman Rokus van Iperen: ‘Rob Pieters can rightly be called one of the founding fathers of the Princess Máxima Center. The Supervisory Board is extremely grateful for the decisive role he played in the establishment and also in the further expansion to where we are now as a leading research hospital in pediatric oncology. We are very pleased that he will be leading the further expansion of our international collaborations.’
Works on the tram track at Padualaan in Utrecht Science Park
To make public transport future-proof, Strukton is carrying out works on the tram track on Padualaan in Utrecht Science Park on behalf of the Province of Utrecht. In mid-January, works on the track will start near Weg tot de Wetenschap, just beyond the tram stop.
High-tech robots and laser scanners: this laboratory is where the food of the future is being discovered.
A remarkable world of high-tech robots, laser scanners, climate chambers, and other advanced equipment is hidden inside an inconspicuous, windowless building at Utrecht Science Park—a world entirely focused on the question of how to feed the global population in 2050.
Together in action for 3FM Serious Request and Spieren voor Spieren
During 3FM Serious Request the whole of the Netherlands came into action for Spieren voor Spieren. A lot of money was raised that can really make a difference for children with a muscular disease: the final amount is € 18,423,566. With the money, Spieren voor Spieren can do research on treatment and medication, faster diagnosis and exercise for children with a muscular disease.
Wennink plan: Life Sciences and biotechnology are important growth drivers for the earning capacity of the Netherlands
The Dutch Life Sciences and biotechnology sector can make a much larger contribution to the Netherlands’ economic strength. This is shown in a new growth strategy presented today as part of Peter Wennink’s advisory report. The report also highlights Utrecht Science Park as one of the key innovation locations and sources of progress and growth.